Selective serotonin 5-HT(1A) receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study

Por Becker, G., Bolbos, R., Costes, N., Redouté, J., Newman-Tancredi, A., Zimmer, L.
Publicado no Sci Rep (2016)

Steric control of CO binding in a totally synthetic heme protein model

Por Busch, Daryle H., Zimmer, L. Lawrence, Grzybowski, Joseph J., Olszanski, Dennis J., Jackels, Susan C., Callahan, Robert C., Christoph, Gary G.
Publicado em 1981

Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial

Por Urbonas, V, Schadendorf, D, Zimmer, L, Danson, S, Marshall, E, Corrie, P, Wheater, M, Plummer, E, Mauch, C, Scudder, C, Goff, M, Love, S B, Mohammed, S B, Middleton, M R
Publicado no Ann Oncol (2019)

TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours

Por Griewank, K G, Murali, R, Schilling, B, Scholz, S, Sucker, A, Song, M, Süsskind, D, Grabellus, F, Zimmer, L, Hillen, U, Steuhl, K-P, Schadendorf, D, Westekemper, H, Zeschnigk, M
Publicado em 2013

Quantitative longitudinal imaging of activated microglia as a marker of inflammation in the pilocarpine rat model of epilepsy using [(11)C]-(R)-PK11195 PET and MRI

Por Yankam Njiwa, J, Costes, N, Bouillot, C, Bouvard, S, Fieux, S, Becker, G, Levigoureux, E, Kocevar, G, Stamile, C, Langlois, JB, Bolbos, R, Bonnet, C, Bezin, L, Zimmer, L, Hammers, A
Publicado no J Cereb Blood Flow Metab (2016)

TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients

Por Dold, L., Zimmer, L., Schwarze-Zander, C., Boesecke, C., Mohr, R., Wasmuth, J.-C., Ommer, K., Gathof, B., Krämer, B., Nattermann, J., Strassburg, C. P., Rockstroh, J. K., Spengler, U., Langhans, B.
Publicado no J Mol Med (Berl) (2020)

Secondary preventive medication persistence and adherence 1 year after stroke

Por Bushnell, C.D., Olson, D.M., Zhao, X., Pan, W., Zimmer, L.O., Goldstein, L.B., Alberts, M.J., Fagan, S.C., Fonarow, G.C., Johnston, S.C., Kidwell, C., LaBresh, K.A., Ovbiagele, B., Schwamm, L., Peterson, E.D.
Publicado em 2011

Differential influence of vemurafenib and dabrafenib on patients’ lymphocytes despite similar clinical efficacy in melanoma

Por Schilling, B., Sondermann, W., Zhao, F., Griewank, K. G., Livingstone, E., Sucker, A., Zelba, H., Weide, B., Trefzer, U., Wilhelm, T., Loquai, C., Berking, C., Hassel, J., Kähler, K. C., Utikal, J., Al Ghazal, P., Gutzmer, R., Goldinger, S. M., Zimmer, L., Paschen, A., Hillen, U., Schadendorf, D.
Publicado no Ann Oncol (2014)